Literature DB >> 21947513

Diagnostic performance of state-of-the-art imaging techniques for morphological assessment of vascular abnormalities in patients with chronic thromboembolic pulmonary hypertension (CTEPH).

Sebastian Ley1, Julia Ley-Zaporozhan, Michael B Pitton, Jens Schneider, Gesine M Wirth, Eckhard Mayer, Christoph Düber, Karl-Friedrich Kreitner.   

Abstract

OBJECTIVES: To determine the most comprehensive imaging technique for the assessment of pulmonary arteries in patients with chronic thromboembolic pulmonary hypertension (CTEPH).
METHODS: 24 patients with CTEPH were examined by ECG-gated multi-detector CT angiography (MD-CTA), contrast-enhanced MR angiography (ce-MRA) and selective digital subtraction angiography (DSA) within 3 days. Two readers in consensus separately evaluated each imaging technique (48 main, 144 lobar and 449 segmental arteries) for typical changes like complete obstructions, vessel cut-offs, intimal irregularities, incorporated thrombus formations, and bands and webs. A joint interpretation of all three techniques served as a reference standard.
RESULTS: Based on image quality, there was no non-diagnostic examination by either imaging technique. DSA did not sufficiently display 1 main, 3 lobar and 4 segmental arteries. The pulmonary trunk was not assessable by DSA. One patient showed thrombotic material at this level only by MD-CTA and MRA. Sensitivity and specificity of MD-CTA regarding CTEPH-related changes at the main/lobar and at the segmental levels were 100%/100% and 100%/99%, of ce-MRA 83.1%/98.6% and 87.7%/98.1%, and of DSA 65.7%/100% and 75.8%/100%, respectively.
CONCLUSION: ECG-gated MD-CTA proved the most adequate technique for assessment of the pulmonary arteries in the diagnostic work-up of CTEPH patients. KEY POINTS: • A prospective single-centre study evaluated ECG-gated MDCTA, ce-MRA and DSA in CTEPH patients. • ECG-gated MD-CT angiography outperformed DSA and ce-MRA. • Right heart catheterisation should be reserved only for assessment of pulmonary haemodynamics.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21947513     DOI: 10.1007/s00330-011-2290-4

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  33 in total

1.  [Contrast-enhanced 3D MR angiography of the pulmonary arteries with integrated parallel acquisition technique (iPAT) in patients with chronic-thromboembolic pulmonary hypertension CTEPH - sagittal or coronal acquisition?].

Authors:  K Oberholzer; B Romaneehsen; P Kunz; T Kramm; M Thelen; K-F Kreitner
Journal:  Rofo       Date:  2004-04

2.  MDCT of right ventricular function: impact of methodologic approach in estimation of right ventricular ejection fraction, part 2.

Authors:  Martine Remy-Jardin; Damien Delhaye; Antoine Teisseire; Claude Hossein-Foucher; Alain Duhamel; Jacques Remy
Journal:  AJR Am J Roentgenol       Date:  2006-12       Impact factor: 3.959

3.  MDCT of right ventricular function: comparison of right ventricular ejection fraction estimation and equilibrium radionuclide ventriculography, part 1.

Authors:  Damien Delhaye; Martine Remy-Jardin; Antoine Teisseire; Claude Hossein-Foucher; Sylvie Leroy; Alain Duhamel; Jacques Remy
Journal:  AJR Am J Roentgenol       Date:  2006-12       Impact factor: 3.959

Review 4.  Proton MRI in COPD.

Authors:  Julia Ley-Zaporozhan; Sebastian Ley; Hans-Ulrich Kauczor
Journal:  COPD       Date:  2007-03       Impact factor: 2.409

5.  Prospectively ECG gated CT pulmonary angiography versus helical ungated CT pulmonary angiography: impact on cardiac related motion artifacts and patient radiation dose.

Authors:  William P Shuman; Jonathon A Leipsic; Janet M Busey; Douglas E Green; Sudhakar N Pipavath; Cameron J Hague; Kent M Koprowicz
Journal:  Eur J Radiol       Date:  2011-06-23       Impact factor: 3.528

6.  Hemodynamic effects of nonionic contrast bolus injection and oxygen inhalation during pulmonary angiography in patients with chronic major-vessel thromboembolic pulmonary hypertension.

Authors:  M B Pitton; C Düber; E Mayer; M Thelen
Journal:  Circulation       Date:  1996-11-15       Impact factor: 29.690

7.  Dual-energy CT angiography for assessment of regional pulmonary perfusion in patients with chronic thromboembolic pulmonary hypertension: initial experience.

Authors:  Edward T D Hoey; Saeed Mirsadraee; Joanna Pepke-Zaba; David P Jenkins; Deepa Gopalan; Nicholas J Screaton
Journal:  AJR Am J Roentgenol       Date:  2011-03       Impact factor: 3.959

8.  Long-term outcome after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension: a single institution experience.

Authors:  Nabil Saouti; Wim J Morshuis; Robin H Heijmen; Repke J Snijder
Journal:  Eur J Cardiothorac Surg       Date:  2009-03-09       Impact factor: 4.191

9.  Chronic thromboembolic pulmonary hypertension: evaluation with 64-detector row CT versus digital substraction angiography.

Authors:  Angela Reichelt; Marius M Hoeper; Michael Galanski; Marc Keberle
Journal:  Eur J Radiol       Date:  2008-05-06       Impact factor: 3.528

10.  Chronic thromboembolic pulmonary hypertension: pre- and postoperative assessment with breath-hold MR imaging techniques.

Authors:  Karl-Friedrich Jakob Kreitner; Sebastian Ley; Hans-Ulrich Kauczor; Eckhard Mayer; Thorsten Kramm; Michael Bernhard Pitton; Frank Krummenauer; Manfred Thelen
Journal:  Radiology       Date:  2004-06-23       Impact factor: 11.105

View more
  22 in total

1.  Novel Thoracic MRI Approaches for the Assessment of Pulmonary Physiology and Inflammation.

Authors:  Jonathan P Brooke; Ian P Hall
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 2.  Chronic pulmonary embolism: diagnosis.

Authors:  Katia Hidemi Nishiyama; Sachin S Saboo; Yuki Tanabe; Dany Jasinowodolinski; Michael J Landay; Fernando Uliana Kay
Journal:  Cardiovasc Diagn Ther       Date:  2018-06

Review 3.  Imaging of pulmonary hypertension: an update.

Authors:  Harold Goerne; Kiran Batra; Prabhakar Rajiah
Journal:  Cardiovasc Diagn Ther       Date:  2018-06

Review 4.  Surgical Management of Chronic Thromboembolic Pulmonary Hypertension.

Authors:  Andrew M Vekstein; Joseph R Nellis; Sharon L McCartney; John C Haney
Journal:  Cardiol Clin       Date:  2022-02       Impact factor: 2.213

Review 5.  Contrast-enhanced CT- and MRI-based perfusion assessment for pulmonary diseases: basics and clinical applications.

Authors:  Yoshiharu Ohno; Hisanobu Koyama; Ho Yun Lee; Sachiko Miura; Takeshi Yoshikawa; Kazuro Sugimura
Journal:  Diagn Interv Radiol       Date:  2016 Sep-Oct       Impact factor: 2.630

6.  Impact of CT perfusion imaging on the assessment of peripheral chronic pulmonary thromboembolism: clinical experience in 62 patients.

Authors:  Julien Le Faivre; Alain Duhamel; Suonita Khung; Jean-Baptiste Faivre; Nicolas Lamblin; Jacques Remy; Martine Remy-Jardin
Journal:  Eur Radiol       Date:  2016-03-14       Impact factor: 5.315

Review 7.  Chronic thromboembolic pulmonary hypertension: detection, medical and surgical treatment approach, and current outcomes.

Authors:  David S Poch; William R Auger
Journal:  Heart Fail Rev       Date:  2016-05       Impact factor: 4.214

8.  Dual-energy CT perfusion and angiography in chronic thromboembolic pulmonary hypertension: diagnostic accuracy and concordance with radionuclide scintigraphy.

Authors:  Gaël Dournes; Damien Verdier; Michel Montaudon; Eric Bullier; Annalisa Rivière; Claire Dromer; François Picard; Marc-Alain Billes; Olivier Corneloup; François Laurent; Mathieu Lederlin
Journal:  Eur Radiol       Date:  2013-08-28       Impact factor: 5.315

Review 9.  Advances in the management of chronic thromboembolic pulmonary hypertension.

Authors:  Demosthenes G Papamatheakis; Nick H Kim
Journal:  Curr Hypertens Rep       Date:  2015-09       Impact factor: 5.369

Review 10.  Optimizing the diagnosis and assessment of chronic thromboembolic pulmonary hypertension with advancing imaging modalities.

Authors:  Seth Kligerman; Albert Hsiao
Journal:  Pulm Circ       Date:  2021-05-24       Impact factor: 3.017

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.